TAK-771-4002: Evaluating the Safety of GAMMAGARD LIQUID for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

11/03/2022
02/07/2024
EU PAS number:
EUPAS46101
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

TAK-771-4002-protocol-original_redact

English (1.52 MB - PDF) View document
Study results
Study results

TAK-771-4002-clinical-study-report-redact

English (1.38 MB - PDF) View document
Study report
Other information